Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness

Carlton K.K. Lee, Donald J. Glenn

Research output: Contribution to journalArticlepeer-review

Abstract

In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18, 618.

Original languageEnglish (US)
Pages (from-to)231-233
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume22
Issue number1-2
DOIs
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness'. Together they form a unique fingerprint.

Cite this